Tagrisso (osimertinib) - AstraZeneca
Zykadia (ceritinib) - Novartis
ATNM-400 - Actinium Pharmaceuticals
Alecensa (alectinib) - Roche
Krazati (adagrasib) - BMS
Xalkori (crizotinib) - Pfizer
Lumakras (sotorasib) - Amgen
https://www.sciencedirect.com/science/article/pii/S3051291326002855?via%3Dihub
 
A. Kamal; S. Mukherjee; J. Li; K. Peregrina; D. Lewis; L. Lumkong; V. Chavez; K. Subramanian; A. S. Chin; M. Roy; J. Kim; S. Kazerounian
 
Sep 29, 2026
 
Prev Next